Depletion of the RNA binding protein HNRNPD impairs homologous recombination by inhibiting DNA-end resection and inducing R-loop accumulation

Nucleic Acids Res. 2019 May 7;47(8):4068-4085. doi: 10.1093/nar/gkz076.

Abstract

DNA double strand break (DSB) repair through homologous recombination (HR) is crucial to maintain genome stability. DSB resection generates a single strand DNA intermediate, which is crucial for the HR process. We used a synthetic DNA structure, mimicking a resection intermediate, as a bait to identify proteins involved in this process. Among these, LC/MS analysis identified the RNA binding protein, HNRNPD. We found that HNRNPD binds chromatin, although this binding occurred independently of DNA damage. However, upon damage, HNRNPD re-localized to γH2Ax foci and its silencing impaired CHK1 S345 phosphorylation and the DNA end resection process. Indeed, HNRNPD silencing reduced: the ssDNA fraction upon camptothecin treatment; AsiSI-induced DSB resection; and RPA32 S4/8 phosphorylation. CRISPR/Cas9-mediated HNRNPD knockout impaired in vitro DNA resection and sensitized cells to camptothecin and olaparib treatment. We found that HNRNPD interacts with the heterogeneous nuclear ribonucleoprotein SAF-A previously associated with DNA damage repair. HNRNPD depletion resulted in an increased amount of RNA:DNA hybrids upon DNA damage. Both the expression of RNase H1 and RNA pol II inhibition recovered the ability to phosphorylate RPA32 S4/8 in HNRNPD knockout cells upon DNA damage, suggesting that RNA:DNA hybrid resolution likely rescues the defective DNA damage response of HNRNPD-depleted cells.

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Camptothecin / pharmacology
  • Checkpoint Kinase 1 / genetics
  • Checkpoint Kinase 1 / metabolism
  • Chromatin / drug effects
  • Chromatin / metabolism*
  • Chromatin / ultrastructure
  • DNA / drug effects
  • DNA Breaks, Double-Stranded / drug effects
  • DNA End-Joining Repair / drug effects
  • DNA, Single-Stranded / genetics
  • DNA, Single-Stranded / metabolism
  • Genome, Human*
  • Genomic Instability
  • HeLa Cells
  • Heterogeneous Nuclear Ribonucleoprotein D0
  • Heterogeneous-Nuclear Ribonucleoprotein D / antagonists & inhibitors
  • Heterogeneous-Nuclear Ribonucleoprotein D / genetics*
  • Heterogeneous-Nuclear Ribonucleoprotein D / metabolism
  • Heterogeneous-Nuclear Ribonucleoprotein U / genetics
  • Heterogeneous-Nuclear Ribonucleoprotein U / metabolism
  • Histones / genetics
  • Histones / metabolism
  • Humans
  • Nucleic Acid Conformation
  • Nucleic Acid Hybridization / drug effects
  • Phosphorylation / drug effects
  • Phthalazines / pharmacology
  • Piperazines / pharmacology
  • RNA Polymerase II / genetics
  • RNA Polymerase II / metabolism
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Recombinational DNA Repair* / drug effects
  • Replication Protein A / genetics*
  • Replication Protein A / metabolism
  • Ribonuclease H / genetics
  • Ribonuclease H / metabolism

Substances

  • Antineoplastic Agents
  • Chromatin
  • DNA, Single-Stranded
  • H2AX protein, human
  • HNRNPD protein, human
  • HNRNPU protein, human
  • Heterogeneous Nuclear Ribonucleoprotein D0
  • Heterogeneous-Nuclear Ribonucleoprotein D
  • Heterogeneous-Nuclear Ribonucleoprotein U
  • Histones
  • Phthalazines
  • Piperazines
  • RNA, Small Interfering
  • Replication Protein A
  • DNA
  • CHEK1 protein, human
  • Checkpoint Kinase 1
  • RNA Polymerase II
  • RPA2 protein, human
  • Ribonuclease H
  • ribonuclease HI
  • olaparib
  • Camptothecin